The invention provides an antibacterial protein (bacteriocin) for the control of Pseudomonas, preferably of Pseudomonas aeruginosa, and to a nucleic acid molecule encoding the bacteriocin. The invention also relates to a composition, notably a pharmaceutical composition, comprising the bacteriocin or a combination of the bacteriocins. The invention further relates to the bacteriocin or composition for use in therapy.
The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
C07K 14/46 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
5.
CHIMERIC BACTERIOCINS AND METHOD FOR THE CONTROL OF PSEUDOMONAS
PseudomonasPseudomonas aeruginosaPseudomonas aeruginosa, and to a nucleic acid molecule encoding the bacteriocin. The invention also relates to a composition, notably a pharmaceutical composition, comprising the bacteriocin or a combination of the bacteriocins. The invention further relates to the bacteriocin or composition for use in therapy.
A product for oral consumption, such as a food, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II and at least one sugar selected from the group consisting of sucrose, glucose, and fructose in a mass ratio of said thaumatin:to said sugar of from 1:2,000 to 1:80,000.
The invention provides a protein having cytotoxic activity against Klebsiella, said protein having a lipid ll-cleaving activity or a pore-forming capability in a cell membrane of Klebsiella.
The invention provides a plus-sense single-stranded RNA viral RNA molecule, comprising a segment encoding a movement protein, a segment encoding a coat protein and a segment that comprises a guide RNA (gRNA), wherein said RNA molecule can be translated, in infected cells, to a polyprotein comprising the movement protein and the coat protein.
C07K 14/46 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
13.
PRODUCTS FOR ORAL CONSUMPTION WITH REDUCED SUGAR CONTENT
A product for oral consumption, such as a food, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II and at least one sugar selected from the group consisting of sucrose, glucose, and fructose in a mass ratio of said thaumatin : to said sugar of from 1 : 2,000 to 1 : 80,000.
A23L 27/00 - SpicesFlavouring agents or condimentsArtificial sweetening agentsTable saltsDietetic salt substitutesPreparation or treatment thereof
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
C07K 14/435 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
The invention provides a plus-sense single-stranded RNA viral RNA molecule, comprising a segment encoding a movement protein, a segment encoding a coat protein and a segment that comprises a guide RNA (gRNA), wherein said RNA molecule can be translated, in infected cells, to a polyprotein comprising the movement protein and the coat protein.
The invention provides a method of preventing or reducing contamination of food with Clostridium, comprising contacting said object with a composition comprising at least one endolysin active against said Clostridium.
C12N 9/36 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme
C07K 14/46 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
19.
Agrobacterium for transient transfection of whole plants
Agrobacterium cells of strain CryX or a derivative strain of strain CryX, wherein said derivative strain has the chromosomal background of strain CryX or said derivative strain contains the vir plasmid of strain CryX or a derivative of said vir plasmid.
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and veterinary preparations, sanitary
preparations for medical purposes, in particular those
developed using genetic engineering. Agricultural, horticultural and forestry products and
grains, live plants, foodstuffs for animals. Research in the field of genetic engineering (with regard to
plants); scientific and industrial research. Medical, hygienic and beauty care, veterinary services,
agricultural services.
The invention provides a method of producing a potexviral vector for expressing a protein of interest in a plant, comprising producing a second heterologous nucleic acid comprising a second ORF encoding said protein and having, in the second ORF, an increased GC-content compared to a first ORF encoding said protein in a first heterologous nucleic acid, and providing said potexviral vector comprising the following segments: (i) a nucleic acid sequence segment encoding a potexviral RNA-dependent RNA polymerase, (ii) a nucleic acid sequence comprising or encoding a potexviral triple-gene block, and (iii) said second heterologous nucleic acid or a portion thereof comprising said second ORF.
05 - Pharmaceutical, veterinary and sanitary products
30 - Basic staples, tea, coffee, baked goods and confectionery
35 - Advertising and business services
Goods & Services
Dietary supplements and dietetic preparations; Herbal supplements; Nutritional supplements; Sugar substitutes for diabetics; Dietetic sugar substitutes for medical use; Artificial sweeteners adapted for diabetics; Medicated food supplements; Preparations for use as additives to food for human consumption [medicated]; Pharmaceutical preparations; Pharmaceuticals; Chemico-pharmaceutical preparations; Chemico-pharmaceutical preparations; Pharmaceuticals and natural remedies. Sugar; Sugar substitutes; Sweeteners (Natural -); Sweeteners (Natural -). Retail services in relation to dietary supplements; Retail services in relation to foodstuffs; Wholesale services in relation to dietary supplements; Wholesale services in relation to foodstuffs; Retailing relating to pharmaceutical and medical articles, and sanitary preparations; Wholesaling relating to pharmaceutical and medical articles, and sanitary preparations.
05 - Pharmaceutical, veterinary and sanitary products
35 - Advertising and business services
Goods & Services
Dietary supplements and dietetic preparations; Herbal supplements; Nutritional supplements; Sugar substitutes for diabetics; Dietetic sugar substitutes for medical use; Artificial sweeteners adapted for diabetics; Medicated food supplements; Preparations for use as additives to food for human consumption [medicated]; Pharmaceutical preparations; Pharmaceuticals; Chemico-pharmaceutical preparations; Chemico-pharmaceutical preparations; Pharmaceuticals and natural remedies. Retail services in relation to dietary supplements; Retail services in relation to foodstuffs; Wholesale services in relation to dietary supplements; Wholesale services in relation to foodstuffs; Retailing relating to pharmaceutical and medical articles, and sanitary preparations; Wholesaling relating to pharmaceutical and medical articles, and sanitary preparations.
The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
The invention provides a method of preventing or reducing contamination of food with Clostridium, comprising contacting said object with a composition comprising at least one endolysin active against said Clostridium.
A61K 38/47 - Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
C12N 9/36 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme
Crop growth management system comprising a process of providing a plant with improved abiotic stress tolerance, comprising providing aerial parts of said plant with a suspension containing cells of an Agrobacterium strain comprising a nucleic acid molecule comprising a nucleic acid construct containing a nucleotide sequence of interest, said nucleotide sequence of interest providing said plant with increased abiotic stress tolerance upon expression in said plant.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Pharmaceutical preparations for internal and topical use, namely vaccines, antibodies, replacement enzymes, cytokines; veterinary preparations for animal health purposes, namely animal vaccines, antibodies, replacement enzymes, cytokines, either purified and as a semi processed plant materials, all of the aforesaid developed using plant biotechnology, sanitary preparations for medical purposes, namely cleaners, antiseptic solutions, sterilizing solutions and disinfecting solutions for use in the pharmaceutical and veterinary fields; agricultural, horticultural and forestry products and grains, namely seed, namely agricultural grains for planting, agricultural seeds, and bulbs for horticultural purposes; live plants and plant-derived materials, namely, additives for use in the manufacture of pharmaceuticals and animal feed additives, medicinal and functional food used for the inhibition of pathogenic bacteria, namely Escherichia coli, Salmonella enteridis and Listeria monocytogenes, foodstuffs for animals including feed additives; animal feed. (1) Research in the field of genetic engineering (with regard to plants), scientific research in the field of genetic engineering of plants; scientific research and industrial research in the field of plant molecular biology, genetics and biotechnology; scientific research in the fields of medicine, hygiene and beauty care, veterinary services, agriculture services, namely pest control, abiotic stress control, weed control, yield control, weed killing, tree care services.
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and veterinary preparations, sanitary preparations for medical purposes, in particular those developed using genetic engineering. Agricultural, horticultural and forestry products and grains, live plants, foodstuffs for animals. Research in the field of genetic engineering (with regard to plants); Scientific and industrial research. Medical, hygienic and beauty care, veterinary services, agricultural services.
30.
AGROBACTERIUM FOR TRANSIENT TRANSFECTION OF WHOLE PLANTS
A process of transiently transfecting a plant or leaves on a plant, comprising contacting said plant or said leaves with a suspension comprising Agrobacterium cells of strain CryX or a derivative strain of strain CryX, wherein said derivative strain has the chromosomal background of strain CryX or said derivative strain contains the vir plasmid of strain CryX or a derivative of said vir plasmid.
A process of producing a preparation of cell wall-degrading enzymes, comprising: expressing in plants or plant parts one or more than one heterologous cell wall-degrading enzyme; harvesting said plants or plant part containing said one or more than one cell wall- degrading enzyme; and storing the harvest as a silage. The silage may be used for degrading cell wall components of plant material or for producing a bioalcohol.
A process of transfecting a plant, comprising spraying parts of said plant with an aqueous suspension containing cells of an Agrobacterium strain and at least one abrasive suspended in said suspension, said Agrobacterium strain comprising a DNA molecule comprising a nucleic acid construct containing a DNA sequence of interest to be transfected into the plant.
